Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Endocrine 2

Conditions

Breast Neoplasms 987Neoplasms 796Carcinoma, Non-Small-Cell Lung 763Prostatic Neoplasms 588Colorectal Neoplasms 484Lung Neoplasms 468Neoplasm Metastasis 413Multiple Myeloma 382Leukemia, Myeloid, Acute 377Ovarian Neoplasms 316Pancreatic Neoplasms 297Melanoma 278Squamous Cell Carcinoma of Head and Neck 258Recurrence 244Carcinoma, Hepatocellular 240Brain Neoplasms 226Glioblastoma 217Triple Negative Breast Neoplasms 204Carcinoma, Renal Cell 200Head and Neck Neoplasms 198Lymphoma 193Stomach Neoplasms 190Precursor Cell Lymphoblastic Leukemia-Lymphoma 189Sarcoma 172Glioma 171Uterine Cervical Neoplasms 169Lymphoma, Non-Hodgkin 169Endometrial Neoplasms 169Lymphoma, Large B-Cell, Diffuse 166Urinary Bladder Neoplasms 160

Interventions

Radiofrequency Ablation 1Adrenalectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Hyperaldosteronism × 90 days × Clear all
NCT05368090 2026-05-08

Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary Aldosteronism

Haukeland University Hospital

Phase NA Recruiting
60 enrolled
Endocrine

Cushing Syndrome, Hyperaldosteronism, Adrenocortical Adenoma

NCT02756754 2026-05-04

ADERADHTA

University Hospital, Toulouse

Phase NA Completed
31 enrolled

ACTH Syndrome, Ectopic, Hyperaldosteronism

NCT07470580 2026-03-13

ADERADHTA2

University Hospital, Toulouse

Phase NA Not yet recruiting
134 enrolled
Endocrine

Hyperaldosteronism, Hypertension, Hypokalemia, Adrenocortical Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡